EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+20.95%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$6.13B
AUM Growth
+$6.13B
(+10%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
175
New
20
Increased
64
Reduced
41
Closed
23
Top Buys
| 1 |
Celldex Therapeutics
CLDX
|
$80.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$56.8M |
| 3 |
Xometry
XMTR
|
$47.8M |
| 4 |
Lexeo Therapeutics
LXEO
|
$40.3M |
| 5 |
monday.com
MNDY
|
$38.4M |
Top Sells
| 1 |
Korro Bio
KRRO
|
$146M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.8M |
| 3 |
Exact Sciences
EXAS
|
$58.1M |
| 4 |
Ascendis Pharma
ASND
|
$49.7M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$47.4M |
Sector Composition
| 1 | Healthcare | 39.38% |
| 2 | Technology | 25.83% |
| 3 | Industrials | 16.87% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Energy | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CDW
CDW
$21.2B
| $41M | 0.67% |
180,520
+11,810
| +7% | +$2.68M |
|
52
Dynavax Technologies
DVAX
$1.19B
| $40.5M | 0.66% |
2,893,435
+1,468,435
| +103% | +$20.5M |
|
|
53
Lexeo Therapeutics
LXEO
$262M
| $40.3M | 0.66% |
+3,002,831
| New | +$40.3M |
|
54
Lattice Semiconductor
LSCC
$9.14B
| $38.3M | 0.63% |
555,329
+127,326
| +30% | +$8.78M |
|
55
Vaxcyte
PCVX
$4.15B
| $38.1M | 0.62% |
607,206
+214,206
| +55% | +$13.5M |
|
56
Crinetics Pharmaceuticals
CRNX
$3.25B
| $37.7M | 0.62% |
1,059,633
+40,851
| +4% | +$1.45M |
|
57
Sprout Social
SPT
$900M
| $36M | 0.59% |
586,739
-402,182
| -41% | -$24.7M |
|
|
NARI
58
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $33.3M | 0.54% |
512,914
| – | – |
|
59
Ferguson
FERG
$46.2B
| $32.9M | 0.54% |
170,362
+24,360
| +17% | +$4.7M |
|
60
O'Reilly Automotive
ORLY
$87.6B
| $29.6M | 0.48% |
31,107
+375
| +1% | +$356K |
|
61
Sherwin-Williams
SHW
$89.9B
| $29.4M | 0.48% |
94,322
+1,205
| +1% | +$376K |
|
62
Synopsys
SNPS
$109B
| $29M | 0.47% |
56,332
-22,673
| -29% | -$11.7M |
|
63
BridgeBio Pharma
BBIO
$10B
| $28.9M | 0.47% |
716,927
| – | – |
|
|
BPMC
64
DELISTED
Blueprint Medicines
BPMC
| $28.8M | 0.47% |
312,374
-126,126
| -29% | -$11.6M |
|
65
Arthur J. Gallagher & Co
AJG
$78.1B
| $28.4M | 0.46% |
126,186
+17,627
| +16% | +$3.96M |
|
66
Williams Companies
WMB
$69.9B
| $27.7M | 0.45% |
796,413
+10,196
| +1% | +$355K |
|
67
Axsome Therapeutics
AXSM
$6.19B
| $27.6M | 0.45% |
346,712
| – | – |
|
|
VRNA
68
Verona Pharma
VRNA
$9.18B
| $27.4M | 0.45% |
1,377,781
+527,781
| +62% | +$10.5M |
|
|
69
Korro Bio
KRRO
$208M
| $26.2M | 0.43% |
546,325
-3,050,797
| -85% | -$146M |
|
70
Workday
WDAY
$62.2B
| $26.1M | 0.43% |
94,464
+1,044
| +1% | +$288K |
|
71
Intuitive Surgical
ISRG
$167B
| $25.9M | 0.42% |
76,694
+295
| +0.4% | +$99.5K |
|
72
Pentair
PNR
$17.5B
| $25.7M | 0.42% |
354,141
+23,891
| +7% | +$1.74M |
|
73
iRhythm Technologies
IRTC
$5.48B
| $25.6M | 0.42% |
239,135
| – | – |
|
74
Inspire Medical Systems
INSP
$2.73B
| $25.4M | 0.42% |
125,090
| – | – |
|
75
Acadia Pharmaceuticals
ACAD
$4.39B
| $25.3M | 0.41% |
+809,391
| New | +$25.3M |
|